Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines
Mark O’Connor
1
,
Andrew Kellett
1
,
Malachy McCann
2
,
Georgina M. Rosair
3
,
MARY MCNAMARA
1
,
Orla Howe
1
,
B. Creaven
4
,
SIOBHAN McCLEAN
4
,
Agnieszka Foltyn Arfa Kia
4
,
Denis O’Shea
1
,
Michael Devereux
1
1
The Inorganic Pharmaceutical
and Biomimetic Research Centre, Focas Research Institute, Dublin Institute of Technology, Camden Row, Dublin
8, Ireland
|
4
Centre of
Applied Science for
Health, Institute of Technology Tallaght Dublin, Tallaght, Dublin 24, Ireland
|
Publication type: Journal Article
Publication date: 2012-02-28
scimago Q1
wos Q1
SJR: 1.801
CiteScore: 11.5
Impact factor: 6.8
ISSN: 00222623, 15204804
PubMed ID:
22313179
Drug Discovery
Molecular Medicine
Abstract
The complexes [Cu(salH)(2)(H(2)O)] (1), [Cu(dipsH)(2)(H(2)O)] (2), {Cu(3-MeOsal)(H(2)O)(0.75)}(n) (3), [Cu(dipsH)(2)(BZDH)(2)] (4), [Cu(dipsH)(2)(2-MeOHBZDH)(2)]·EtOH (5), [Cu(sal)(phen)] (6), [Cu(dips)(phen)]·H(2)O (7), and [Cu(3-MeOsal)(phen)]·H(2)O (8) (salH(2) = salicylic acid; dipsH(2) = 3,5-diisopropylsalicylic acid; 3-MeOsalH(2) = 3-methoxysalicylic acid; BZDH = benzimidazole; 2-MeOHBZDH = 2 methanolbenzimidazole and phen =1,10-phenanthroline) were prepared and characterized. Structures of 4, 5, and 8 were determined by X-ray crystallography. Compounds 1-8 are potent superoxide dismutase mimetics, and they are inactive as inhibitors of COX-2 activity. Compounds 1, 4, and 5 exhibit moderate inhibition of COX-1. Complexes 6-8 display rapid micromolar cytotoxicity against cisplatin sensitive (breast (MCF-7), prostate (DU145), and colon (HT29)) and cisplatin resistant (ovarian (SK-OV-3)) cell lines compared to 1-5, and they exhibit potent in vitro DNA binding and cleavage capabilities.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
18
|
|
|
Journal of Inorganic Biochemistry
17 publications, 11.04%
|
|
|
Polyhedron
9 publications, 5.84%
|
|
|
Journal of Molecular Structure
8 publications, 5.19%
|
|
|
Inorganica Chimica Acta
7 publications, 4.55%
|
|
|
European Journal of Medicinal Chemistry
6 publications, 3.9%
|
|
|
New Journal of Chemistry
5 publications, 3.25%
|
|
|
RSC Advances
5 publications, 3.25%
|
|
|
Dalton Transactions
5 publications, 3.25%
|
|
|
Journal of Coordination Chemistry
5 publications, 3.25%
|
|
|
Molecules
4 publications, 2.6%
|
|
|
Journal of Biological Inorganic Chemistry
4 publications, 2.6%
|
|
|
European Journal of Inorganic Chemistry
4 publications, 2.6%
|
|
|
Applied Organometallic Chemistry
4 publications, 2.6%
|
|
|
Journal of Structural Chemistry
4 publications, 2.6%
|
|
|
Inorganic Chemistry Communication
3 publications, 1.95%
|
|
|
Zeitschrift fur Anorganische und Allgemeine Chemie
3 publications, 1.95%
|
|
|
Chemistry - A European Journal
3 publications, 1.95%
|
|
|
Current Medicinal Chemistry
2 publications, 1.3%
|
|
|
Frontiers in Chemistry
2 publications, 1.3%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.3%
|
|
|
Scientific Reports
2 publications, 1.3%
|
|
|
Journal of Solid State Chemistry
2 publications, 1.3%
|
|
|
Coordination Chemistry Reviews
2 publications, 1.3%
|
|
|
Chemical Biology and Drug Design
2 publications, 1.3%
|
|
|
Inorganic Chemistry
2 publications, 1.3%
|
|
|
Bioinorganic Chemistry and Applications
2 publications, 1.3%
|
|
|
Mendeleev Communications
1 publication, 0.65%
|
|
|
Russian Journal of Inorganic Chemistry
1 publication, 0.65%
|
|
|
Oncotarget
1 publication, 0.65%
|
|
|
2
4
6
8
10
12
14
16
18
|
Publishers
|
10
20
30
40
50
60
70
|
|
|
Elsevier
64 publications, 41.56%
|
|
|
Wiley
20 publications, 12.99%
|
|
|
Royal Society of Chemistry (RSC)
16 publications, 10.39%
|
|
|
Springer Nature
12 publications, 7.79%
|
|
|
MDPI
8 publications, 5.19%
|
|
|
American Chemical Society (ACS)
7 publications, 4.55%
|
|
|
Pleiades Publishing
5 publications, 3.25%
|
|
|
Taylor & Francis
5 publications, 3.25%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 1.3%
|
|
|
Frontiers Media S.A.
2 publications, 1.3%
|
|
|
IOP Publishing
2 publications, 1.3%
|
|
|
Walter de Gruyter
2 publications, 1.3%
|
|
|
Hindawi Limited
2 publications, 1.3%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.65%
|
|
|
Impact Journals
1 publication, 0.65%
|
|
|
Chinese Academy of Sciences
1 publication, 0.65%
|
|
|
AIP Publishing
1 publication, 0.65%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.65%
|
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
154
Total citations:
154
Citations from 2024:
19
(12.33%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
O’Connor M. et al. Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines // Journal of Medicinal Chemistry. 2012. Vol. 55. No. 5. pp. 1957-1968.
GOST all authors (up to 50)
Copy
O’Connor M., Kellett A., McCann M., Rosair G. M., MCNAMARA M., Howe O., Creaven B., McCLEAN S., Foltyn Arfa Kia A., O’Shea D., Devereux M. Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines // Journal of Medicinal Chemistry. 2012. Vol. 55. No. 5. pp. 1957-1968.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1021/jm201041d
UR - https://doi.org/10.1021/jm201041d
TI - Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines
T2 - Journal of Medicinal Chemistry
AU - O’Connor, Mark
AU - Kellett, Andrew
AU - McCann, Malachy
AU - Rosair, Georgina M.
AU - MCNAMARA, MARY
AU - Howe, Orla
AU - Creaven, B.
AU - McCLEAN, SIOBHAN
AU - Foltyn Arfa Kia, Agnieszka
AU - O’Shea, Denis
AU - Devereux, Michael
PY - 2012
DA - 2012/02/28
PB - American Chemical Society (ACS)
SP - 1957-1968
IS - 5
VL - 55
PMID - 22313179
SN - 0022-2623
SN - 1520-4804
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2012_O’Connor,
author = {Mark O’Connor and Andrew Kellett and Malachy McCann and Georgina M. Rosair and MARY MCNAMARA and Orla Howe and B. Creaven and SIOBHAN McCLEAN and Agnieszka Foltyn Arfa Kia and Denis O’Shea and Michael Devereux},
title = {Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines},
journal = {Journal of Medicinal Chemistry},
year = {2012},
volume = {55},
publisher = {American Chemical Society (ACS)},
month = {feb},
url = {https://doi.org/10.1021/jm201041d},
number = {5},
pages = {1957--1968},
doi = {10.1021/jm201041d}
}
Cite this
MLA
Copy
O’Connor, Mark, et al. “Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines.” Journal of Medicinal Chemistry, vol. 55, no. 5, Feb. 2012, pp. 1957-1968. https://doi.org/10.1021/jm201041d.